166 related items for PubMed ID: 38713460
1. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
2. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
3. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 27; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
4. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 27; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
5. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 27; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
6. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
7. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
8. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 21; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
9. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
10. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
Eur J Pediatr; 2019 Mar 21; 178(3):315-322. PubMed ID: 30499051
[Abstract] [Full Text] [Related]
11. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Mar 21; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
12. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
Int Immunopharmacol; 2023 Sep 21; 122():110600. PubMed ID: 37423157
[Abstract] [Full Text] [Related]
13. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 Sep 21; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
14. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
Int J Clin Pract; 2022 Sep 21; 2022():2726686. PubMed ID: 35989868
[Abstract] [Full Text] [Related]
15. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 21; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
16. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan 21; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
17. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
Shimizu M, Mizuta M, Usami M, Inoue N, Sakakibara Y, Yamada K, Konishi M, Ohta K, Yachie A.
Cytokine; 2018 Aug 21; 108():168-172. PubMed ID: 29625336
[Abstract] [Full Text] [Related]
18. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Aug 21; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
19. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
20. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
J Pediatr (Rio J); 2023 Jun 25; 99(4):406-412. PubMed ID: 36977496
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
